Zion Market Research In Vitro Diagnostics (IVD) Market, 2016–2024 | Page 4

In Vitro Diagnostics (IVD) Market
North America is anticipated to be the dominating region in the global in vitro diagnostics
market owing to the increasing aging population, easy convenience to technologically
improved products, rising adoption of personalized medicine, increasing incidence of
changing lifestyle and genetic disorders, and existence of a huge figure of important in vitro
diagnostics manufacturers. Europe is also expected to grow at a higher rate in the near
future. Even the Asia Pacific region is assumed to grow in the market at a significant rate in
the coming period. The growth of this region can be attributed to the advancing healthcare
framework and improving economies in India and China.
Global In Vitro Diagnostics (IVD) Market: Competitive Players
The key players in the global in the Vitro diagnostics market are Thermo Fisher Scientific,
Inc., Danaher Corporation, Abbott Laboratories, Becton, Dickinson and Company, Siemens
Healthiness, and Roche Diagnostics. The other major players in the market include Sysmex
Corporation, Ortho-Clinical Diagnostics, Inc., Johnson and Johnson, bioMérieux, Bio-Rad
Laboratories, Inc., Qiagen N.V., and Diasorin S.P.A.
Browse detail report @ https://www.zionmarketresearch.com/report/global-in-vitro-
diagnostics-market
Global In Vitro Diagnostics (IVD) Market by Regional Segment Analysis: North America
(U.S.); Europe(UK, France, Germany); Asia-Pacific(China, Japan, India); Latin
Ame rica(Brazil); The Middle East and Africa
Our value reports provide full, in-depth analysis of the parent market including most